Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) Equity Income (2018 - 2025)

Historic Equity Income for Sanara MedTech (SMTI) over the last 6 years, with Q3 2025 value amounting to -$288642.0.

  • Sanara MedTech's Equity Income fell 81783.9% to -$288642.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$686291.0, marking a year-over-year increase of 84.31%. This contributed to the annual value of -$90007.0 for FY2024, which is 13585.45% down from last year.
  • Per Sanara MedTech's latest filing, its Equity Income stood at -$288642.0 for Q3 2025, which was down 81783.9% from -$195482.0 recorded in Q2 2025.
  • In the past 5 years, Sanara MedTech's Equity Income registered a high of -$31448.0 during Q3 2024, and its lowest value of -$660678.0 during Q4 2022.
  • Its 4-year average for Equity Income is -$215907.0, with a median of -$179769.0 in 2021.
  • Per our database at Business Quant, Sanara MedTech's Equity Income crashed by 28294.55% in 2022 and then crashed by 81783.9% in 2025.
  • Over the past 4 years, Sanara MedTech's Equity Income (Quarter) stood at -$144180.0 in 2021, then tumbled by 358.23% to -$660678.0 in 2022, then soared by 91.14% to -$58559.0 in 2024, then crashed by 392.91% to -$288642.0 in 2025.
  • Its Equity Income stands at -$288642.0 for Q3 2025, versus -$195482.0 for Q2 2025 and -$143608.0 for Q1 2025.